IgG-Guided Elimination Diet Beneficial for Irritable Bowel Syndrome
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 20, 2025 -- Patients with irritable bowel syndrome (IBS) on an immunoglobulin (Ig)G-guided elimination diet are more likely to have a 30 percent or greater reduction in abdominal pain intensity (API), according to a study published online Jan. 31 in Gastroenterology.
Prashant Singh, M.B.B.S., from Michigan Medicine in Ann Arbor, and colleagues conducted a randomized, double-blind trial involving patients with IBS from eight centers to examine the efficacy of an elimination diet utilizing a novel IBS-specific IgG assay. A total of 238 patients positive for one or more foods on an 18-food IgG assay and with an average daily API score between 3 and 7.5 on an 11-point scale during a two-week run-in period were randomly assigned to eight weeks of either an experimental antibody-guided diet or sham diet. The modified intention-to-treat analysis included 223 patients.
The researchers found that significantly more patients in the experimental diet group than the sham diet group met the primary outcome of a ≥30 percent decrease in API for two or more of the last four weeks of the treatment period (59.6 versus 42.1 percent). Compared with the sham group, a significantly higher proportion of patients in the experimental group with constipation-predominant IBS (IBS-C) and IBS with mixed bowel habits (IBS-M) met the primary end point (67.1 versus 35.8 percent and 66 versus 29.5 percent, respectively).
"Given our promising results, a larger study, possibly focusing on IBS-C and IBS-M patients, should be considered," the authors write.
Several authors disclosed ties to biotechnology and pharmaceutical companies, including Biomerica, which funded the study.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-21 06:00
Read more

- Housing Discrimination Increases Cancer Death Risk Among Young Patients
- Trump Pauses Disbursement of Global HIV Treatment Funds
- Epstein-Barr Virus Might Help Trigger Cancer After Kidney Transplant
- More Sunshine in Pregnancy, Infancy Could Benefit Kids With MS
- Parental Sociodemographics Linked to Child MMR Vaccine Uptake
- Vitamin Deficiencies Common in Type 2 Diabetes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions